Interferon receptor binding peptides
OwnerEleanor N. Fishinventor
Life of this patent
Estimating the term…
Abstract
A polypeptide for use as an interferon receptor-binding peptide, said polypeptide selected from the group of peptides having an amino acid sequence substantially of the formulae; CYS-LEU-LYS-ASP-ARG-HIS-ASP; ASP-GLU-SER-LEU-LEU-GLU-LYS-PHE-TYR-THR-GLU-LEU-TYR-GLN-LEU-ASN-ASP; ASN-GLU-THR-ILE-VAL-GLU-ASN-LEU-LEU-ALA-ASN-VAL-TYR-HIS-GLN-ILE-ASN-HIS; TYR-LEU-THR-GLU-LYS-LYS-TYR-SER-PRO-CYS-ALA; TYR-PHE-GLN-ARG-ILE-THR-LEU-TYR-LEU-THR-GLU-LYS-LYS-TYR-SER-PRO-CYS-ALA; TYR-PHE-GLN-ARG-ILE-THR-LEU-TYR; and GLU-LEU-TYR-GLN-GLN-LEU-ASN-ASP. The polypeptides are useful for delivering a pharmaceutically active drug to a cell.
Claims8
A novel IFN-receptor binding peptide having an amino acid sequence of the formula:
- CYS-LEU-LYS-ASP-ARG-HIS-ASP (SEQ. ID NO. 1).
A novel IFN-receptor binding peptide having an amino acid sequence of the formula:
- ASP-GLU-SER-LEU-LEU-GLU-LYS-PHE-TYR-THR-GLU-LEU-TYR-GLN-GLN-LEU-ASN-ASP (SEQ. ID NO. 2).
A novel IFN-receptor binding peptide having an amino acid sequence of the formula:
- ASN-GLU-THR-ILE-VAL-GLU-ASN-LEU-LEU-ALA-ASN-VAL-TYR-HIS-GLN-ILE-ASN-HIS (SEQ. ID NO. 3).
A novel IFN-receptor binding peptide having an amino acid sequence of the formula:
- TYR-LEU-THR-GLU-LYS-LYS-TYR-SER-PRO-CYS-ALA (SEQ. ID NO. 4).
A novel IFN-receptor binding peptide having an amino acid sequence of the formula:
- TYR-PHE-GLN-ARG-ILE-THR-LEU-TYR-LEU-THR-GLU-LYS-HYS-TYR-SER-PRO-CYS-ALA (SEQ. ID NO. 5).
A novel IFN-receptor binding peptide having an amino acid sequence of the formula:
- TYR-PHE-GLN-ARG-ILE-THR-LEU-TYR (SEQ. ID NO. 6).
A novel IFN-receptor binding peptide having an amino acid sequence of the formula:
- GLU-LEU-TYR-GLN-GLN-LEU-ASN-ASP (SEQ. ID NO. 7).
A polypeptide for use as an interferon-receptor binding peptide, said polypeptide selected from the group of peptides having an amino acid sequence of the formulae:
- CYS-LEU-LYS-ASP-ARG-HIS-ASP (SEQ. ID NO. 1);
- ASP-GLU-SER-LEU-LEU-GLU-LYS-PHE-TYR-THR-GLU-LEU-TYR-GLN-GLN-LEU-ASN-ASP (SEQ. ID NO. 2);
- ASN-GLU-THR-ILE-VAL-GLU-ASN-LEU-LEU-ALA-ASN-VAL-TYR-HIS-GLN-ILE-ASN-HIS (SEQ. ID NO. 3);
- TYR-LEU-THR-GLU-LYS-LYS-TYR-SER-PRO-CYS-ALA (SEQ. ID NO. 4);
- TYR-PHE-GLN-ARG-ILE-THR-LEU-TYR-LEU-THR-GLU-LYS-LYS-TYR-SER-PRO-CYS-ALA (S EQ. ID NO. 5);
- TYR-PHE-GLN-ARG-ILE-THR-LEU-TYR (SEQ. ID NO. 6);
- and GLU-LEU-TYR-GLN-GLN-LEU-ASN-ASP (SEQ. ID NO. 7).
Dependencies are inferred from the claim text.